Q&A highlights: Decentralized manufacturing: enabling scalable and cost-effective point of care for cell and gene therapies - RegMedNet
Thermo Fisher Scientific expands viral vector manufacturing capabilities in US
Thermo Fisher Scientific on LinkedIn: Webinar: Enabling Scalable and Cost-Effective Point of Care for Cell and…
Looking Ahead: Optimizing Cell and Gene Therapy Manufacturing in a Post-COVID World
Workshop: Industrialization of Cell Therapy Manufacturing—Lessons Learned from Biologics | Thermo Fisher Scientific - TW
Thermo Fisher Launches Cell And Gene Therapy Mfg. Offering | Contract Pharma
Thermo Fisher Scientific and Scinogy partner to accelerate cell and gene therapy commercialization — Scinogy
BioInsights - Advances in AAV process development
Thermo Fisher Launches Medium to Support Cell, Gene Therapy
Thermo Fisher Scientific - We've completed our acquisition of PeproTech, a leading developer and manufacturer of recombinant proteins for cell and gene therapies. PeproTech's portfolio will complement our existing cell culture media
Thermo Fisher sketches out Carlsbad plasmid DNA plant as German cell and gene therapy facility preps for opening | Fierce Pharma
Thermo Fisher to buy gene, cell therapy maker; AstraZeneca's Forxiga gets EU nod | S&P Global Market Intelligence
COVID-19 Challenges for Cell and Gene Therapy Development
Lifesci majors Thermo Fisher, Charles River join bid to automate cell therapy
Thermo Fisher to offer cell and gene therapy packaging services
Thermo Fisher Introduces New Cell And Gene Therapy Services | Contract Pharma
Thermo Fisher Scientific and Scinogy Partner to Accelerate Cell and Gene Therapy Commercialization | Technology Networks
Industry-Leading Product, Compliance and Services Offering Facilitates cGMP-Compatible Cell and Gene Therapy Manufacturing
Thermo Fisher buys into gene therapy with $1.7 billion deal
